$0.6691
-0.0197-2.86%
Last update: Nov 9, 5:32 PM
Tiziana Life Sciences Ltd
TLSANASDAQ
Tiziana Life Sciences fell 61.8% from $1.75 to $0.67, behind the S&P 500's +10.5%. Its worst day was Nov 2 (−16.2%), and its low came Nov 5 at $0.62.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Tiziana Life Sciences closed at its highest level of the year, 4.0% above where the year started.
+5.2% · S&P 500 +0.9%
Story events cover the past 12 months · Times ET
Tiziana Life Sciences shares rose 15.9%, while the S&P 500 fell 0.1%.
+15.9% · S&P 500 −0.1%
EPS of $-0.16 missed the $-0.13 estimate on $0.00 revenue.
+3.7% · S&P 500 −0.4%
Tiziana Life Sciences shares rose 16.7%, while the S&P 500 rose 1.0%.
+16.7% · S&P 500 +1.0%
Tiziana Life Sciences shares rose 26.0%, while the S&P 500 rose 0.9%.
+26.0%, the year's best day · S&P 500 +0.9%
Tiziana Life Sciences shares rose 16.4%, while the S&P 500 fell 0.2%.
+16.4% · S&P 500 −0.2%
Trial met its dual primary endpoints for (1) statistically significant reduction (p=0.0168) in microglial activation as measured by TSPO PET imaging in patients treated with 50 ug nasal foralumab as compared to placebo
−16.2%, the year's worst day · S&P 500 −0.5%
Where it ended: a close of $0.67 on Nov 9, 2026.
Nothing in the past 12 months.
All TLSA dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for TLSA and SPY from Benzinga historical bars. Not investment advice.
